Based in Arlington, VA, Caribou is an automotive fintech platform dedicated to transforming consumers’ financial relationship with their cars. Caribou’s seamless and transparent process leverages partnerships with trusted lenders and insurance providers to bring customers great rates and lower monthly payments.
Website: https://www.gocaribou.com/
Sector: P&C (Personal / Specialty)
Year Invested: 2021
Website: https://www.gocaribou.com/
Sector: P&C (Personal / Specialty)
Year Invested: 2021
Location: United States, District of Columbia, Washington
Total raised: $115M
Valuation: $1.1B
Investors 7
| Date | Name | Website |
| 22.11.2021 | IA Capital... | iacapgroup... |
| 15.11.2021 | Link Ventu... | linkventur... |
| - | QED Invest... | qedinvesto... |
| - | Flucas Ven... | flucasvc.c... |
| - | Curql | curql.com |
| - | Construct ... | constructc... |
| 02.05.2022 | Moderne Ve... | moderneven... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.05.2022 | Series C | $115M | - |
Mentions in press and media 3
| Date | Title | Description |
| 16.02.2022 | Power Moves: This global expert is the new CEO of DC’s Crypto Council for Innovation | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us: dc@technical.ly.Meet the new local(ish) face of cryptocurrency Look, you’re probably sick of hearing abou... |
| 10.11.2021 | Leading Auto Refinance Platform MotoRefi Rebrands to Caribou | Caribou ...We work towards expanding Caribou into a full-fledged digital agency... WASHINGTON (PRWEB) November 10, 2021 MotoRefi, the leading auto refinance platform, launched an elevated and expanded brand in connection with announcing a c... |
| 03.03.2021 | Caribou nets $115M to boost CRISPR tech, advance off-the-shelf cell therapies W e b i n a r The role of clinical adjudication in trial efficiency and data quality for interstitial lung disease (ILD) | On the heels of a new partnership with AbbVie, Caribou Biosciences is reeling in $115 million to keep improving its CRISPR technology and shepherd its pipeline of allogeneic, or off-the-shelf, cell therapies into and through the clinic. BD&... |